Reuters - Shire Plc's drug to treat severe swelling caused by a rare genetic disorder showed effectiveness in a key clinical trial, U.S. Food and Drug Administration staff said on Tuesday.
You are here:
Health 
Diseases & Conditions Shire drug for rare swelling worked in trial: FDA
(Reuters)
Diseases & Conditions Shire drug for rare swelling worked in trial: FDA
(Reuters)
